Recent Advances in Dipeptidyl-Peptidase-4 Inhibition Therapy: Lessons from the Bench and Clinical Trials

DPP4 inhibitors (DPP4i) are a class of newly developed antidiabetic drugs which preserve incretin hormones and promote postprandial insulin secretion. Although the cardiovascular effect of DPP4 inhibition has been substantially studied, the exact role of DPP4 in cardiovascular disease especially in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Jixin, Gong, Quan, Goud, Aditya, Srinivasamaharaj, Srividya, Rajagopalan, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446505/
https://www.ncbi.nlm.nih.gov/pubmed/26075284
http://dx.doi.org/10.1155/2015/606031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446505/
https://www.ncbi.nlm.nih.gov/pubmed/26075284
http://dx.doi.org/10.1155/2015/606031

Ejemplares similares